Ryan Maddox, PhD, Epidemiologist, CDC
Watch Presentation: 2020 CDC Update on Prion Disease
Download Presentation |
Simon Mead, Consultant Neurologist & Clinical Lead, UK National Prion Clinic, National Hospital for Neurology & Neurosurgery
Watch Presentation: Genetic Prion Disease and How Genetics Might Help Us Understand Sporadic CJD
Download Presentation |
Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals
Watch Presentation: Antisense Oligonucleotides for Prion Disease |
Brian Appleby, MD, Medical Director, CJD Foundation, and Director, National Prion Disease Pathology Surveillance Center
Watch Presentation: National Prion Disease Pathology Surveillance Center Update |
CJD Foundation Research Grant Recipient Reports Panel 1
- Sonia Vallabh, PhD, Broad Institute of MIT and Harvard
Assessing efficacy of zinc-finger repressors of prion protein as a therapeutic for prion disease
- Dr. Holger Wille, University of Alberta
Evaluating prion vaccines in transgenic mouse models of familial prion diseases
Watch Presentation |
CJD Foundation Research Grant Recipient Reports Panel 2
- Fei Wang, PhD, The University of Texas Health Science Center at Houston
Generating Recombinant Human Prions in Large Scale for Structural Studies
- Rodrigo Morales, PhD, The University of Texas Health Science Center at Houston
Exploring the zoonotic potential of porcine-derived materials from animals exposed to infectious prions
- Dr. Gabriel Haller and Brooke Sadler, PhD, Washington University School of Medicine
The Contribution of Rare Variant and Copy-Number Variation to Risk of Sporadic CJD and Pleiotropy with Other Neurodegenerative Diseases
- Candace Mathiason, PhD, Prion Research Center, Colorado State University
Use of Blood-borne Prion Amplification Assays for the Detection of Human Prion Diseases and Biomarker Assessment
Watch Presentation |
CJD Foundation Research Grant Recipient Reports Panel 3
- Anna Poleggi, PhD, Istituto Superiore di Sanità , Rome
Investigating the influence of CYP4X1 gene of age at onset of CJD as potential preventive therapeutic approach
- Qingzhong Kong, PhD, Case Western Reserve University
The RAP approach for effective prevention and treatment of prion diseases
- Natalia do Carmo Ferreira de Araujo, PhD, Rocky Mountain Laboratories, NIH/NIAID
Evaluation of new anti-prion drugs: from drug design to therapeutic efficacy against human prions in vitro, ex-vivo and in vivo
Watch Presentation |